Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy

ClinicalTrials.gov ID: NCT03176472

Public ClinicalTrials.gov record NCT03176472. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 3:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy

Study identification

NCT ID
NCT03176472
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Regenacy Pharmaceuticals LLC
Industry
Enrollment
282 participants

Conditions and interventions

Interventions

  • ricolinostat Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 6, 2020
Primary completion
Oct 30, 2022
Completion
Apr 27, 2023
Last update posted
Sep 20, 2023

2020 – 2023

United States locations

U.S. sites
35
U.S. states
16
U.S. cities
33
Facility City State ZIP Site status
Pinnacle Research Group LLC Anniston Alabama 36207
Arizona Research Center Phoenix Arizona 85053
Diabetes/Lipid Management & Research Center Huntington Beach California 92648
National Research Institute Huntington Park California 90255
Altman Clinical and Translational Research Institute La Jolla California 92037
Torrance Clinical Research Institute Inc Lomita California 90717
Providence Clinical Research North Hollywood California 91606
Center for Clinical Research Inc San Francisco California 94115
Diablo Clinical Research Inc Walnut Creek California 94598
Innovative Research of West Florida Inc Clearwater Florida 33756
DeLand Clinical Research Unit Lake Mary Florida 32746
ClinCloud LLC Maitland Florida 32751
APF Research LLC Miami Florida 33134
International Research Associates LLC Miami Florida 33183
Sensible Healthcare LLC Ocoee Florida 34761
Progressive Medical Research Port Orange Florida 32127
Meridien Research Tampa Florida 33634
Metabolic Research Institute Inc West Palm Beach Florida 33401
Physicians Research Associates, LLC Lawrenceville Georgia 30046
Rocky Mountain Clinical Research Idaho Falls Idaho 83404
MediSphere Medical Research Center, LLC Evansville Indiana 47714
Tandem Clinical Research Marrero Louisiana 70072
Olive Branch Family Medical Center Olive Branch Mississippi 38654
Advanced Biomedical Research of America Las Vegas Nevada 89123
Hassman Research Institute Berlin New Jersey 08009
NY Scientific Brooklyn New York 11235
Triad Clinical Trials Greensboro North Carolina 27410
The Center for Clinical Research Winston-Salem North Carolina 27103
Coastal Carolina Research Center North Charleston South Carolina 29405
Palmetto Clinical Research Summerville South Carolina 29485
FutureSearch Trials of Neurology Austin Texas 78731
Nerve and Muscle Center of Texas Houston Texas 77030
Sun Research Institute San Antonio Texas 78215
Diabetes & Glandular Disease Clinic, P.A. San Antonio Texas 78229
Wasatch Clinical Research LLC Salt Lake City Utah 84107

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03176472, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 20, 2023 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03176472 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →